{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T04:15:22Z","timestamp":1783656922184,"version":"3.55.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2018,4,4]],"date-time":"2018-04-04T00:00:00Z","timestamp":1522800000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Pain Headache Rep"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1007\/s11916-018-0685-5","type":"journal-article","created":{"date-parts":[[2018,4,4]],"date-time":"2018-04-04T06:23:18Z","timestamp":1522822998000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":69,"title":["America\u2019s Opioid Epidemic: a Comprehensive Review and Look into the Rising Crisis"],"prefix":"10.1007","volume":"22","author":[{"given":"Peter S.","family":"Ostling","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly S.","family":"Davidson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Best O.","family":"Anyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik M.","family":"Helander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melville Q.","family":"Wyche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan D.","family":"Kaye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,4,4]]},"reference":[{"issue":"3","key":"685_CR1","doi-asserted-by":"crossref","first-page":"E445","DOI":"10.36076\/ppj.2015\/18\/E445","volume":"18","author":"L Manchikanti","year":"2015","unstructured":"Manchikanti L, Atluri S, Hirsch JA. The effect of abuse-deterrent extended-release oxycodone leads to inappropriate conclusions with over estimation of safety of abuse-deterrent formulations. Pain physician. 2015;18(3):E445\u20136.","journal-title":"Pain physician"},{"issue":"26","key":"685_CR2","doi-asserted-by":"publisher","first-page":"697","DOI":"10.15585\/mmwr.mm6626a4","volume":"66","author":"GP Guy Jr","year":"2017","unstructured":"Guy GP Jr, Zhang K, Bohm MK, Losby J, Lewis B, Young R, et al. Vital signs: changes in opioid prescribing in the United States, 2006-2015. MMWR Morb Mortal Wkly Rep. 2017;66(26):697\u2013704.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"33","key":"685_CR3","doi-asserted-by":"publisher","first-page":"837","DOI":"10.15585\/mmwr.mm6533a2","volume":"65","author":"RM Gladden","year":"2016","unstructured":"Gladden RM, Martinez P, Seth P. Fentanyl law enforcement submissions and increases in synthetic opioid-involved overdose deaths\u201427 states, 2013-2014. MMWR Morb Mortal Wkly Rep. 2016;65(33):837\u201343.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"2","key":"685_CR4","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1007\/s11524-016-0113-2","volume":"94","author":"B Ray","year":"2017","unstructured":"Ray B, Quinet K, Dickinson T, Watson DP, Ballew A. Examining fatal opioid overdoses in Marion County, Indiana. J Urban Health. 2017;94(2):301\u201310.","journal-title":"J Urban Health"},{"issue":"14","key":"685_CR5","doi-asserted-by":"publisher","first-page":"382","DOI":"10.15585\/mmwr.mm6614a2","volume":"66","author":"NJ Somerville","year":"2017","unstructured":"Somerville NJ, O'Donnell J, Gladden RM, Zibbell JE, Green TC, Younkin M, et al. Characteristics of fentanyl overdose\u2014Massachusetts, 2014-2016. MMWR Morb Mortal Wkly Rep. 2017;66(14):382\u20136.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"7","key":"685_CR6","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1056\/NEJMp1615145","volume":"376","author":"RG Frank","year":"2017","unstructured":"Frank RG, Pollack HA. Addressing the fentanyl threat to public health. N Engl J Med. 2017;376(7):605\u20137.","journal-title":"N Engl J Med"},{"key":"685_CR7","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.drugpo.2017.05.051","volume":"46","author":"S Slavova","year":"2017","unstructured":"Slavova S, Costich JF, Bunn TL, Luu H, Singleton M, Hargrove SL, et al. Heroin and fentanyl overdoses in Kentucky: epidemiology and surveillance. Int J Drug Policy. 2017;46:120\u20139.","journal-title":"Int J Drug Policy"},{"issue":"33","key":"685_CR8","doi-asserted-by":"publisher","first-page":"844","DOI":"10.15585\/mmwr.mm6533a3","volume":"65","author":"AB Peterson","year":"2016","unstructured":"Peterson AB, Gladden RM, Delcher C, Spies E, Garcia-Williams A, Wang Y, et al. Increases in fentanyl-related overdose deaths\u2014Florida and Ohio, 2013-2015. MMWR Morb Mortal Wkly Rep. 2016;65(33):844\u20139.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"47","key":"685_CR9","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.15585\/mmwr.mm6547e1","volume":"65","author":"C Wejnert","year":"2016","unstructured":"Wejnert C, Hess KL, Hall HI, Van Handel M, Hayes D, Fulton P Jr, et al. Vital signs: trends in HIV diagnoses, risk behaviors, and prevention among persons who inject drugs\u2014United States. MMWR Morb Mortal Wkly Rep. 2016;65(47):1336\u201342.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"685_CR10","unstructured":"Medicaid expansion: behavioral health treatment use in selected states in 2014. 2017. Report No.: GAO-17-529."},{"issue":"1","key":"685_CR11","first-page":"64","volume":"29","author":"National Federation of Independent Business V","year":"2013","unstructured":"National Federation of Independent Business V. Sebelius, 132 S.Ct. 2566 (June 2012). Benefits Q. 2013;29(1):64\u20136.","journal-title":"Benefits Q"},{"key":"685_CR12","doi-asserted-by":"crossref","unstructured":"Maclean J, Saloner, B. The effect of public insurance expansions on substance use disorder treatment: evidence from the Affordable Care Act In: Research NBoE, editor. 2017.","DOI":"10.3386\/w23342"},{"issue":"1","key":"685_CR13","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1080\/08897077.2015.1080208","volume":"37","author":"RM Burns","year":"2016","unstructured":"Burns RM, Pacula RL, Bauhoff S, Gordon AJ, Hendrikson H, Leslie DL, et al. Policies related to opioid agonist therapy for opioid use disorders: the evolution of state policies from 2004 to 2013. Subst Abus. 2016;37(1):63\u20139.","journal-title":"Subst Abus"},{"key":"685_CR14","unstructured":"Opioid addiction: laws, regulations, and other factors can affect medication-assisted treatment access. In: Office USGA, editor. 2016."},{"key":"685_CR15","unstructured":"Rinaldo SG, Rinaldo RW. Availability without accessibility: state Medicaid coverage and authorization requirements for opioid dependence medications 2013 [Available from: https:\/\/www.asam.org\/docs\/default-source\/advocacy\/aaam_implications-for-opioid-addiction-treatment_final ."},{"key":"685_CR16","unstructured":"H.R.2634 - Drug Addiction Treatment Act of 2000."},{"key":"685_CR17","unstructured":"FDA. Subutex and suboxone approved to treat opiate dependence 2002 [Available from: https:\/\/www.fda.gov\/Drugs\/DrugSafety\/ucm191521.htm ."},{"issue":"23","key":"685_CR18","doi-asserted-by":"publisher","first-page":"2213","DOI":"10.1056\/NEJMp1609578","volume":"375","author":"R Gupta","year":"2016","unstructured":"Gupta R, Shah ND, Ross JS. The rising price of naloxone\u2014risks to efforts to stem overdose deaths. N Engl J Med. 2016;375(23):2213\u20135.","journal-title":"N Engl J Med"},{"issue":"2","key":"685_CR19","doi-asserted-by":"publisher","first-page":"184","DOI":"10.5055\/jom.2015.0267","volume":"11","author":"X Ruan","year":"2015","unstructured":"Ruan X, Ma L, Couch JP, Chen T, Bumgarner GW. Intractable pruritus during outpatient epidural hydromorphone infusion: a case report and a focused review of the literature. J Opioid Manag. 2015;11(2):184\u201390.","journal-title":"J Opioid Manag"},{"issue":"2","key":"685_CR20","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/s40122-016-0062-1","volume":"5","author":"J Gudin","year":"2016","unstructured":"Gudin J. Oxycodone DETERx(R): a novel abuse-deterrent, extended-release analgesic option for the treatment of patients with chronic pain. Pain Ther. 2016;5(2):171\u201386.","journal-title":"Pain Ther"},{"key":"685_CR21","doi-asserted-by":"crossref","unstructured":"Morlion BJ, Mueller-Lissner SA, Vellucci R, Leppert W, Coffin BC, Dickerson SL, et al. Oral prolonged-release oxycodone\/naloxone for managing pain and opioid-induced constipation: a review of the evidence. Pain Pract. 2017.","DOI":"10.1111\/papr.12646"},{"issue":"1","key":"685_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s40122-014-0026-2","volume":"3","author":"AZ DePriest","year":"2014","unstructured":"DePriest AZ, Miller K. Oxycodone\/naloxone: role in chronic pain management, opioid-induced constipation, and abuse deterrence. Pain Ther. 2014;3(1):1\u201315.","journal-title":"Pain Ther."},{"issue":"11","key":"685_CR23","doi-asserted-by":"publisher","first-page":"2142","DOI":"10.1111\/pme.12834","volume":"16","author":"J Gudin","year":"2015","unstructured":"Gudin J, Levy-Cooperman N, Kopecky EA, Fleming AB. Comparing the effect of tampering on the oral pharmacokinetic profiles of two extended-release oxycodone formulations with abuse-deterrent properties. Pain Med. 2015;16(11):2142\u201351.","journal-title":"Pain Med"},{"key":"685_CR24","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1007\/s11916-016-0565-9","volume":"20","author":"MR Jones","year":"2016","unstructured":"Jones MR, Carney MJ, Kaye RJ, Prabhakar A, Kaye AD. Drug formulation advances in extended-release medications for pain control. Curr Pain Headache Rep. 2016;20:36.","journal-title":"Curr Pain Headache Rep"},{"issue":"7\u20138","key":"685_CR25","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/S0027-9684(15)30175-9","volume":"104","author":"J Bonhomme","year":"2012","unstructured":"Bonhomme J, Shim RS, Gooden R, Tyus D, Rust G. Opioid addiction and abuse in primary care practice: a comparison of methadone and buprenorphine as treatment options. J Natl Med Assoc. 2012;104(7\u20138):342\u201350.","journal-title":"J Natl Med Assoc"},{"issue":"5","key":"685_CR26","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1097\/ADM.0000000000000045","volume":"8","author":"MR Lofwall","year":"2014","unstructured":"Lofwall MR, Walsh SL. A review of buprenorphine diversion and misuse: the current evidence base and experiences from around the world. J Addict Med. 2014;8(5):315\u201326.","journal-title":"J Addict Med"},{"key":"685_CR27","doi-asserted-by":"crossref","unstructured":"\u2022\u2022 Kaye AD, Jones MR, Kaye AM, Ripoll JG, Galan V, Beakley BD, et al. Prescription opioid abuse in chronic pain: an updated review of opioid abuse predictors and strategies to curb opioid abuse: part 1. Pain Physician. 2017;20(2S):S93\u2013S109. This is an excellent review on prescription opioid abuse.","DOI":"10.36076\/ppj.2017.s109"},{"key":"685_CR28","doi-asserted-by":"crossref","unstructured":"\u2022\u2022 Kaye AD, Jones MR, Kaye AM, Ripoll JG, Jones DE, Galan V, et al. Prescription opioid abuse in chronic pain: an updated review of opioid abuse predictors and strategies to curb opioid abuse (part 2). Pain Physician. 2017 Feb;20(2S):S111\u201333. This is an excellent review on prescription opioid abuse.","DOI":"10.36076\/ppj.2017.s111"},{"key":"685_CR29","doi-asserted-by":"crossref","unstructured":"\u2022\u2022 Manchikanti L, Kaye AM, Knezevic NN, McAnally H, Slavin K, Trescot AM, et al. Responsible, safe, and effective prescription of opioids for chronic non-cancer pain: American Society of Interventional Pain Physicians (ASIPP) guidelines. Pain Physician. 2017;20(2S):S3\u2013S92. This is an excellent review on opioids for noncancer pain.","DOI":"10.36076\/ppj.2017.s92"}],"container-title":["Current Pain and Headache Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11916-018-0685-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11916-018-0685-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11916-018-0685-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,18]],"date-time":"2022-08-18T00:25:00Z","timestamp":1660782300000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11916-018-0685-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,4]]},"references-count":29,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,5]]}},"alternative-id":["685"],"URL":"https:\/\/doi.org\/10.1007\/s11916-018-0685-5","relation":{},"ISSN":["1531-3433","1534-3081"],"issn-type":[{"value":"1531-3433","type":"print"},{"value":"1534-3081","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,4]]},"assertion":[{"value":"4 April 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"Dr. Ostling, Dr. Davis, Dr. Helander, and Dr. Wyche declare no conflicts of interest.Dr. Kaye is a speaker for Depomed, Inc. and Merck, Inc. He also reports that he has been a member of the FDA Advisory Board on Anesthetics, Analgesics, and Addiction Medicine since 2012.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}],"article-number":"32"}}